Related references
Note: Only part of the references are listed.Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker
Ka Yin Lui et al.
BMC CANCER (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Expression of GOLPH3 protein in colon cancer tissues and its association with the prognosis of patients
Bo Zhou et al.
ONCOLOGY LETTERS (2016)
GOLPH3 Links the Golgi, DNA Damage, and Cancer
Matthew D. Buschman et al.
CANCER RESEARCH (2015)
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway
Ting Dai et al.
JOURNAL OF PATHOLOGY (2015)
Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma A Meta-Analysis
Wenjun Liao et al.
MEDICINE (2015)
Increased Expression of GOLPH3 is Associated with the Proliferation of Prostate Cancer
Wenzhi Li et al.
JOURNAL OF CANCER (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
GOLPH3, a Good Prognostic Indicator in Early-stage NSCLC Related to Tumor Angiogenesis
Ming Lu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
DNA Damage Triggers Golgi Dispersal via DNA-PK and GOLPH3
Suzette E. Farber-Katz et al.
CELL (2014)
Mechanisms of GOLPH3 Associated with the Progression of Gastric Cancer: A Preliminary Study
Jinzhen Peng et al.
PLOS ONE (2014)
High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma
Guang-Sheng Hu et al.
TUMOR BIOLOGY (2014)
Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer
Ben-Shun Hu et al.
TUMOR BIOLOGY (2013)
Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor
Zhaolei Zeng et al.
CLINICAL CANCER RESEARCH (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis
Jinxu Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
Huan Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers
Jung Il Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
Masakuni Tateyama et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
Pisit Tangkijvanich et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
Kenneth L. Scott et al.
NATURE (2009)
Systemic therapy of hepatocellular carcinoma: Are we making progress?
Patricia Roxburgh et al.
ADVANCES IN THERAPY (2008)
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Han C. Dan et al.
GENES & DEVELOPMENT (2008)
PKBα/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival
Lana Bozulic et al.
MOLECULAR CELL (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
New perspectives and strategy research biomarkers for hepatocellular carcinoma
Raphael Saffroy et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Serum markers of hepatocellular carcinoma
H. C. Spangenberg et al.
SEMINARS IN LIVER DISEASE (2006)
mTOR•RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes
RC Hresko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients
JA Marrero et al.
HEPATOLOGY (2003)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
Share Paper
